Menu
Back to User profile » Dr Hongluan Mao
Papers published by Dr Hongluan Mao:
Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
Bai G, Zhou Y, Rong Q, Qiao S, Mao H, Liu P
Journal of Inflammation Research 2023, 16:1227-1241
Published Date: 23 March 2023
Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
Huang X, Wei X, Qiao S, Zhang X, Li R, Hu S, Mao H, Liu P
Cancer Management and Research 2021, 13:9015-9024
Published Date: 6 December 2021
Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
Zhang X, Wei X, Bai G, Huang X, Hu S, Mao H, Liu P
Cancer Management and Research 2021, 13:8629-8646
Published Date: 16 November 2021
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P
OncoTargets and Therapy 2020, 13:5069-5082
Published Date: 8 June 2020
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:9793-9794
Published Date: 15 November 2019
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:8063-8074
Published Date: 3 October 2019
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P
OncoTargets and Therapy 2014, 7:587-597
Published Date: 23 April 2014